Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Por Delwart, E L, Pan, H, Sheppard, H W, Wolpert, D, Neumann, A U, Korber, B, Mullins, J I
Publicado em 1997

Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients with or without HIV Infection

Por Cortez, K.J., Proschan, M.A., Barrett, L., Brust, D.G., Formentini, E., Davey, R.T., Masur, H., Polis, M.A., Neumann, A.U., Kottilil, S.
Publicado no HIV Clin Trials (2013)

Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response

Por ROTMAN, Y., BORG, B. B., SOZA, A., FELD, J. J., MODI, A. A., LOOMBA, R., LUTCHMAN, G., RIVERA, E., DOO, E., GHANY, M. G., HELLER, T., NEUMANN, A. U., LIANG, T. J., HOOFNAGLE, J. H.
Publicado em 2010

Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines

Por Connor, R. I., Korber, B. T. M., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., Fenamore, E., Cao, Y., Gao, F., Kalams, S., Kunstman, K. J., McDonald, D., McWilliams, N., Trkola, A., Moore, J. P., Wolinsky, S. M.
Publicado em 1998